Why Attend
Reproductive health is set to hold a leading market share of women’s health industry, with an estimated global worth of $171 billion by 2027.
Start-ups, Femtech, and Technology innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.
The Reproductive Health Innovation Summit (15-16 February) is the destination for uncovering what is next in fertility, contraception, and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices and solutions, and new care delivery models.
Join us to:
- Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.
- Dive into 1 of our 3 leading innovation topics: Contraception, Fertility or Maternal Health, to discover the latest research, innovations, and sector-specific challenges and opportunities.
- Network with the leaders and changemakers, with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.
Add to the innovation, and attend alongside our leading network of, biotech’s, start-ups, Femtech, insurers, CRO’s, investors, medical device companies, researchers, pharmaceuticals, HCP’s and advocacy groups, to drive innovation at the convergence of healthcare and technology.
2022 Innovation Spotlight
Showcasing the most innovative and disruptive companies in reproductive health.
2022 FINALISTS WINNER ANNOUNCED
CONTRALINE
We would like to congratulate Contraline for winning the 2022 Reproductive Health Innovation Summit!
Here's a little bit about our showcase winner:
Contraline is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAM, the world’s first long-lasting, non-hormonal, and non-permanent contraceptive for men. The company was founded in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia.
2022’S PRESTIGIOUS SELECTION COMMITTEE OF INVESTORS
2022 Partners
Platinum Partners
Presagen
Website: https://www.presagen.com/
Presagen is an AI healthcare company focused on improving Women's health outcomes globally. Presagen's Social Network for Healthcare that is changing the way clinics, patients, and medical data from around the world are connected through AI. Our online data-sharing and collaboration network enables clinics and patients to connect, safely share data, use AI healthcare services, and get rewarded. With an initial focus in Women’s Health, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for patients.
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
Gold Partners
ICON PLC
Website: https://iconplc.com/
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employs approximately 16,000 employees in 93 locations in 41 countries. Further information is available at www.iconplc.com.
Granata Bio
Website: https://www.granata.bio/
Granata Bio is a biopharma company focused on women's health and infertility. Founded in 2018, Granata Bio’s model is to identify and in-license strategic products for development and commercialization in North America. The company recently announced a partnership with IBSA Group (Lugano, CH) to co-develop a novel subcutaneous progesterone solution in the United States.
For more information, please visit www.granata.bio. Follow on Twitter, Instagram, and LinkedIn.
Axia WH
Website: https://axiawh.com/
Axia Women's Health is leading the way in improving women's health. At the core of achieving this is a caring, connected, and progressive community of more than 400 providers and nearly 200 women's health centers across Pennsylvania, New Jersey, Indiana, Ohio, and Kentucky. The rapidly growing network spans OB/GYN physicians, breast health centers, high-risk pregnancy centers, a central laboratory, urogynecology, and fertility centers. Together, Axia Women's Health puts women first by delivering the personalized care needed for women to lead healthier, happier lives.
Nixon Peabody LLP
Website: https://www.nixonpeabody.com/en
Nixon Peabody LLP is a full-service law firm with 600 attorneys across 16 locations throughout the United States as well as in China and London. Our diverse platform offers clients the right combination of local resources and international experience. We deliver sophisticated legal services to our clients and our communities by combining high performance, entrepreneurial spirit, deep engagement, and an unwavering commitment to a culture of collaboration, diversity, and humanity. Specifically, our Healthcare Group is viewed as a top legal competitor across the industry, serving as a trusted advisor as we guide clients strategies for health care delivery, corporate organization, government programs, emerging payment programs, managed care models, and more. We partner with organizations across all sectors of the healthcare industry, on a range of services, including ancillary and specialty services, corporate transactions, digital health, financing, government investigations, health care litigation, health information management and privacy, network formation, regulatory compliance, and reimbursement and value-based contracting.
Cambridge Design Partnership
Website: http://www.cambridge-design.com/femtech
Cambridge Design Partnership is an end-to-end innovation partner, propelling global brands and ambitious start-ups to success.
We build breakthrough products and services – from insight to ideas, prototypes to production – bringing innovation to life. Our teams are multi-disciplinary, uniting scientific rigor, design ingenuity, and engineering excellence for consumer, healthcare, and industrial clients. People-centered, deeply collaborative, and – above all – expert, we’re uniquely positioned to shape the future for consumers, patients, and industry.
Not all people are the same. Our FemTech philosophy integrates inclusivity, experience-led design, and the smart integration of technology. By putting people and context at the center of our thinking – and applying consumer and healthcare knowledge gathered globally by our multi-disciplinary team – we help our partners create meaningful incremental and transformational innovations that improve lives.
One partner. No barriers. Extraordinary results.
Media Partners
Women of Wearables
Website: https://www.womenofwearables.com/
Women of Wearables is the first global organisation that supports and connects women in wearable tech, fashion tech, health tech, IoT and VR/AR.
Its mission is to encourage more women and diverse teams to participate in building hardware and software products as designers, product managers and developers or being founders of their own companies, as well as create more jobs for women in STEM. With headquarters in London (UK) and more than 20,000 members located around the globe, WoW supports its growing community of women and girls in the tech space through monthly meetups, panels, mentorship and collaboration with its network of local ambassadors, partners and communities. WoW is not just for professional women, but for anyone with an interest in emerging technologies and providing women with a platform for growth.
FemTech Focus
Website: www.femtechfocus.org
Femtech Focus is a 501c3 non-profit entity empowering the femtech industry through increased awareness of femtech in the tech world, providing resources to femtech founders, and creating opportunities to support femtech startups through exposure, networking, and access to capital.
How we are contributing to women's health space:
Femtech Focus has a popular podcast with thousands of listeners around the world. This supports our efforts to increase awareness of the femtech industry.
Femtech Focus is launching a femtech accelerator this Fall. Follow our social pages and subscribe to our newsletter to know when applications open!
@FemtechFocus - Facebook, Twitter, Instagram, Linkedin
Expanding Medication Abortion Access (EEMA)
Website: https://emaaproject.org/
The EMAA Project seeks to improve the way the medications prescribed for medication abortion care are dispensed in the United States, to make the process consistent with the medical and scientific evidence and to meet women’s needs
Femtech Insider
Website: https://femtechinsider.com/
Femtech Insider is the go-to platform for all things femtech. We’re the fastest growing portal for innovation in women’s health and address the information needs of founders, investors, researchers and consumers alike.
Springboard
Website: https://sb.co
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. We are a leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
Piggyback Health
Website: https://piggybackhealth.com/
Piggyback Health is an advisory platform to level up your understanding of next generation women’s health. We are 100% focused on early stage Femtech. Our mission is: “To connect investors and high potential startups in Femtech in order to facilitate funding, heighten awareness, and bring new opportunities for social equity to groups we care about, globally.”
We sell research reports and custom services to inform due diligence and strategic planning in this burgeoning, high energy space advancing women’s health. Reach out for a free consult at [email protected]. Visit us at piggybackhealth.com.
Fempower health
Website: http://fempower-health.com/
Fempower Health focused on empowering women to be the CEO of their health. Women are often "trained" to grin and bear it, rather than being offered research-backed solutions (mostly because the research is incredibly limited). Women deserve better: better insight and better solutions. Over 80 women’s health experts on women’s health issues have been interviewed on the Fempower Health Podcast covering how to navigate the complex healthcare system, reproductive health, menopause, the pelvic floor, pregnancy, sexual health and general women’s health.
2022 Speakers
Elena Gambon
Alice Zheng, MD, MBA, MPH
David Sable
Elizabeth Garner
Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance. As a member of ObsEva’s Executive Committee, she provides strategic leadership on the Company’s overall development strategy and frequently represents ObsEva to investor, Key Opinion Leader (KOL), and other key stakeholders.
From 2014 to 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics, located in Princeton, NJ. She played a crucial role during Agile’s 2014 Initial Public Offering and was instrumental in the Company’s Investor Relations, Communications, and Business Development strategies. Dr. Garner led the clinical development of Twirla®, Agile’s low-dose contraceptive patch, took the Company through an FDA dispute resolution process, and was the presenter and moderator for Agile’s successful FDA Advisory Committee meeting in October 2019, which led to FDA approval of Twirla® in February, 2020. She also led pre-launch activities, including commercial support, medical affairs, KOL development, and the pharmacovigilance and Medical Information programs.
Prior to her position at Agile, Dr. Garner was Vice President of Medical Affairs, Preventive Care at Myriad Genetics, where she managed the women’s health research, publication, and KOL development programs, provided medical and scientific input on Myriad’s marketing and new product strategies, served as its media spokesperson, and directed an experienced team of Field Medical Specialists. Before that, she was Senior Director at Abbott Laboratories, where she oversaw all clinical aspects of the global Phase 3 endometriosis development program for elagolix, which was FDA-approved in 2018.
From 2007 to 2011, Dr. Garner was Associate Director then Director of Clinical Research at Merck Research Laboratories. As a leader on the human papillomavirus (HPV) vaccine program she was instrumental in achieving successful outcomes on important regulatory submissions. Dr. Garner also served as chair of the Gardasil®9 HPV vaccine program Product Development Team, leading scientific, regulatory, global access and medical affairs strategies. Dr. Garner was the presenter and moderator for the successful 2010 FDA Gardasil® Advisory Committee Meeting. She also had substantial involvement in commercialization strategy and KOL development, and participated in due diligence on infectious disease and women’s health products.
Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s/Dana Farber Cancer Institute. Prior to entering the pharmaceutical industry, Dr. Garner focused on academic clinical practice, basic science research in ovarian cancer, and teaching and mentorship of fellows, residents, and medical students at Harvard Medical School. She is an author on numerous peer-reviewed scientific papers.
Dr. Garner is a member of the Board of Directors of Kezar Life Sciences, a publicly traded company focused on the development of new therapies targeting protein homeostasis for the treatment of autoimmune diseases and cancer. She serves on the board’s audit and clinical strategy & execution committees. She is also on the Board of Directors of the Drug Information Association (DIA), a member-driven volunteer organization for global healthcare product development; she serves on the audit committee. She is on the Board of Directors and is Chair of the finance committee of the American Medical Women’s Association, a professional organization which functions at the local, national, and international level to advance women in medicine. Dr. Garner also serves on the Board of the Executive Women of New Jersey and was a 2018 honoree at its Salute to the Policy Makers gala, which recognizes executive women leaders across all industries. She is also on the Board of CorStone, a global non-profit organization focused on resilience in youth. Dr. Garner was a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry.
Ru-fong Joanne Cheng
Edio Zampaglione
Kelle Moley, MD
Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation. Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.
Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.
Katie Williams
Mikayla Johnson
Dr. Raoul Scherwitzl
Nathanial DeNicola
Dr. Patrick Carroll
Akash Bakshi
Lisa Campo-Engelstein
Sasha Ottey, MHA, MT, (ASCP)
Shelley Alpern
Amanda Gorman
Sara Naseri
Reenita Das
Katie Schubert
Jamie White
Heather Vahdat
Thomas Crouzier
Priyanka Jain
Anula Jayasuriya
Audrey Anderson Duckett
Brian T. Nguyen
Elizabeth Bailey
Linda Greub
Deena Shakir
Casey Santiago
Casey Albert Santiago has 20 years of global operating experience building, scaling and investing in women’s health companies. Casey is a Managing Partner at SteelSky Ventures, a female-led venture capital fund investing in early-stage companies that improve access, care, and outcomes in women's health. Prior to joining SteelSky, Casey invested in early-stage digital health & consumer health start-ups in partnership with Johnson & Johnson. She was CEO/Founder of Kangu, a maternal health tech platform that was acquired in 2018, and was an early product leader at Kiva, which has facilitated billions of dollars in microloans to female entrepreneurs in the US and globally. Casey serves as an advisor to a number of venture-backed women’s health start-ups and speaks frequently on entrepreneurship and women’s health. She holds a BA from Wellesley College, an MBA from Columbia Business School.
Jackie Rotman
Evan Sussman
Michelle Perugini
Rachel Scherl
Rachel Blank
Dr. Neel Shah
Alison Malmqvist
Emma Kemble
Prepared gyn oncology client for future value and market access hurdles and advised on incorporating value and access in both clinical and business development
Developed strategy and identified the next wave of growth for a pharmacy benefit manager
Assessed key trends in pharmaceutical pricing and access in the US and determined implications for client
Amy Fan
Bruno van Tuykom
Sarah Cairns-Smith
Carli Sapir
Polly Rodriguez
Lauren Wang
Dr. Rem Koning
Dana Northcraft
Vrunda Desai
Dr. Denny Sakkas
Dr.Lynn Westphal
Dr. Barbara Stegmann
Elizabeth Cherot
Dr. Elizabeth Cherot is Chief Medical Officer with Axia Women’s Health, a rapidly growing network of progressive, connected, and caring women’s health professionals with more 400 providers and nearly 200 locations across five states. She is an established and highly skilled physician with over 20 years of experience in obstetrics and gynecology. In addition to her expert clinical skills, she is committed to improving OB/GYN care, reducing morbidity and mortality while implementing cost reduction and providing an efficient business model for today’s OB/GYN practice.
Dr. Cherot has been awarded numerous honors throughout her career including several National Excellence in Teaching Awards. She has also helped to pioneer the Enhanced Recovery after Surgery program in the United States, contributing to a significant reduction of opioid using in post-partum women.
In addition to being an accomplished clinician, Dr. Cherot holds an Executive MBA from Johns Hopkins University Carey School of Business. She resides in Central New Jersey with her husband and two children.
Dr. Kristyn Brandi
Melissa Grant
Monica Lee
Sarah Swank
As a former senior in-house counsel for two national health care systems, Sarah Swank provides strategic, regulatory and operational advice to health systems, hospitals and academic medical centers, as well as large national and regional physician organizations and telehealth and other startups.
Alexandra Busto
Alexandra Busto is an associate in the Health Care group. She works with academic medical centers, hospitals, long-term care facilities, surgery centers, foundations and clinics, medical groups/IPAs, accountable care organizations, and other entities affiliated with the health care industry. Alex also represents companies in the health information, medical device, and telehealth fields.
Polly Rodriguez
Dr. Kenneth Carson
Dr. Kenneth Carson is a practicing physician and recognized expert in the area of real-world evidence generation. After medical school graduation at the University of Southern California, he completed residency training in internal medicine at Duke University and fellowship training in hematology and medical oncology at Northwestern University. Later, as a faculty member at Washington University in St. Louis, he received a PhD in public health from the University of Illinois. During his time as a Wash U faculty member, he developed and mentored a research team that used the large national databases from the department of Veterans Affairs to investigate treatment patterns and outcomes in patients with cancer and pre-cancerous conditions. Based upon this research success, he became chief of hematology and oncology at the St. Louis VA medical center. Five years ago, he transitioned the majority of his time to industry, working first at Flatiron Health in New York, and later at Tempus Labs in Chicago, where he is currently Vice-President of Clinical Solutions. Both Flatiron and Tempus are major players in the rapidly growing industry of real-world data in oncology. Today, in addition to seeing patients every week at Rush University, Dr. Carson works with a variety of pharmaceutical and provider stakeholders to solve major challenges in oncology drug development.
Cath Everett
Download 2022 agenda
Be the first to view our 2021 Reproductive Health Innovation Summit agenda!
Sessions include:
- Investment, Innovation & Reproductive Health: Where does Technology Stand today?
- The IVF Clinic Market of the Future: Exploring the Impact of PE investment
- Male Reproductive Health & The Impact on Women's Health
- Sex & Gender in Medicine, Research & Practice
Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!
Download the Reproductive Health Innovation Summit Agenda
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
Covid-19 Update for attending Reproductive Health Innovation Summit, February 15th – 16th 2022
As of January 15th, 2022, a Covid-19 vaccination mandate will come in to affect in the city of Boston. This mandate means that anyone attending an event must be double vaccinated and provide proof of this prior to attending the event. Anyone with a medical or religious exemption is not permitted to attend any event in line with the Boston city mandate. Further details on the Covid-19 vaccination mandate can be found by clicking here.
The Boston Park Plaza hotel will be enforcing this for any event taking place within their hotel. For more information on what the Boston Park Plaza are doing to ensure the safety of guests and visitors to the hotel click here.
To ensure we meet all mandate and hotel rules, we will be asking anyone attending the Reproductive Health Innovation Summit to be double vaccinated and to provide proof of this by sending us a copy of your vaccination card via email. Anyone who is not double vaccinated will not be permitted to attend; as the venue will not accept testing in lieu of vaccination, and in line with the city of Boston mandate.
REGISTRATION
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
TICKET PRICES INCREASE IN
VENUE
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
